How Novartis Stock Did in June
Novartis (NVS), which specializes in researching, developing, manufacturing, and marketing a broad range of healthcare products, reports its business under three segments: Innovative Medicines, Sandoz (generics), and Alcon (eye care). The chart below shows Novartis’s revenue and EPS since Q1 2017, and analysts’ estimate for Q2 2018.